Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Novartis
Novartis
Ludwig Institute for Cancer Research
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Astellas Pharma Inc
NYU Langone Health
Case Comprehensive Cancer Center